Arthritis Flashcards

1
Q

what is primary OA

A

idiopathic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is secondary OA

A

post - traumatic
underlying cause or event or congenital malformation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

prevalance of OA

A

302 mil world wide
1 in 4 people in US

leading cause of disability in older adults

spands decades of life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

most commonly affects joints

A

hips
knees
hands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

clinical features of OA

A

loss of articular cartilage

synovitis

boney changes

ligamentous changes

meniscal changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

patient impct of OA

A

Pain- -secondary affects contribute to the pain such as synovitis not necessarily loss of cartilage

Swelling – occur w synovitis

Stiffness – walking/moving on it less

Loss of Function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

OA pathophysiology

A

degenerative process of the whole joint with different phenotypes emerging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

risk factors for primary OA

A

age
obesity/metabolic disease
sex (60% female(

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

major components of normal cartilage

A

water
extracellular matrix (ECM) and proteoglycans
chondrocytes (responsible for both catabolism and anabolism)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

function of cartilage

A

Withstand highly repetitive compressive and shear loads, maintain a near frictionless joint surface environment, allow force transmission between articulating bones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

physiology and biomechanics of normal cartilage

A

Uses hydrodynamics- water flows out in response to compression

Proteoglycans are hydrophilic, attract water to flow back into cartilage following water loss

Combination of hydrodynamics and ECM structure allow compressive forces to be converted to shear at the calcified cartilage/bone interface

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

cartilage regeneration of normal cartilage

A

Chondrocytes repair ECM (very slow process) (Otero 2012, Eyre 2006) -> poor healing potential (Buckwalter 1998)

Chondrocytes are mechanosensitive, regenerative process is stimulated in response to loading (Gilbert 2018)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

impairment of cartilage regeneration of OA

A

Regeneration is too slow to keep up with damage repair AND/OR regeneration pathway is altered
- Presence of inflammation impacts chondrocyte function
–Produce more pro-inflammatory markers and matrix degrading enzymes
–Early chondrocyte senescence (Liu-Bryan 2015) = death

Proteoglycan loss occurs first, followed by eventual ECM breakdown
-Loses ability to handle loads via hydrodynamics (less water), placing more stress on ECM

Articular Cartilage Breakdown
–This process is going on for YEARS/DECADES before we can see cartilage breakdown
–Translation: By the time we start to see cartilage breakdown its far too late

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

secondary OA due to an associated event could be

A

joint injury: PTOA
- knee injury 6x risk increases

abnormal alignment or geometry
- malalignment of the knee is on independent risk of OA progression

The normal joint structure and biomechanics are impacted resulting in both inflammatory environment and changes to loading environment
Slow cartilage metabolism does not adapt quickly enough to joint changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

PTOA

A

The major issue:
250k ACLR yearly (mostly impacting people under 25)
~50% will have radiographic OA within 10-20 yrs

Translation:
- Huge cohort of young individuals with old knees
–Lots of years left in the medical system
—Downstream healthcare impacts of physical inactivity and/or disability
–Joint arthroplasty only lasts~ 20 yrs
—These people may need multiple arthroplasties in their lifetime = $$$$$

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

summary of OA?

A

Much more complex than originally thought (not just wear and tear)
Cartilage regeneration is unable to keep up with microdamage
Impacted by biomechanics and/or inflammatory environment
Impacts the whole joint (not just articular cartilage)
We don’t fully understand what causes symptoms
Worse radiographic OA more likely to have symptoms
Primary OA: Intersection between aging, genetics, metabolic syndrome/obesity, lifestyle choices
Secondary OA: Intersection between joint biomechanics and inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

common imaging features

A

Loss of joint space width
Osteophyte formation
Sclerosis of subchondral bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

imaging modalities

A

radiographs (gold standard)
MRI
CT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

grade 1 OA

A

possible osteophites
doubtful JSN
doubtful OA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

grade 2

A

definite osteophites
possible JSN
mild OA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

grade 3 OA

A

moderate osteophites
definite JSN
moderate OA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

grade 4 OA

A

large osteophites
great JSN
severe OA

22
Q

grade 0 OA

A

no OA
no osteophites
no jsn

23
Q

OA imaging

A

Advanced Imaging Techniques

New promising imaging sequences that allow us to assess cartilage physiology before cartilage damage is evident

MRI T1rho: Associated proteoglycan content/concentration

MRI T2*: Associated with ECM orientation and free vs bound water

24
Q

OA treatment

A

We currently have zero treatments that have been proven effective at reversing OA or stopping its progression
The treatments we do have:
Treat the symptoms (reduce pain)
Promote function
Prevent OA from happening in the first place
Injury prevention (Secondary OA)
Lifestyle (Primary OA)
Moderate Activity
Weight Management

25
Q

OA medical management treatment for NSAIDS

A

Effective at reducing pain and targeting synovitis
Cheap
Cons: Some with comorbidities unable to use
Some have topical versions available
Con: Treats symptoms, no impact on disease

26
Q

common NSAIDS OA treatment

A

Ibuprofen
Naproxen
Diclofenac

27
Q

pharm interventions for OA

A

NSAIDs
Corticosteroids
Hyaluronic Acid
Biologics

28
Q

surgery interventions for OA

A

Debridement
Cartilage Repair
Joint Replacement

29
Q

corticosteroids treatment

A

common: cortisone injections (kenalog)

tx: Effective at reducing short-term pain and inflammation
Intended to be an adjunct
More localized treatment
Cons: Some with comorbidities unable to use
Con: Treats symptoms, no impact on disease
Con: Limited dosage schedule, infection risk

30
Q

hyaluronic acid for OA

A

common: Viscosupplementation)
Synvisc
Hyalgen
Euflexxa

treatment:
Can improve symptoms and function in mild/moderate OA (high bias evidence)
“lubricates” the joint
Cons: Expensive (limited insurance coverage)
Con: Treats symptoms, no impact on disease
Con: Limited dosage schedule

31
Q

biologics for OA tx

A

Common:
Stem Cell Therapy
Platelet Rich Plasma (PRP)

Treatment:
Promising basic science results
Some mixed results but mostly poor findings of effectiveness in vivo
No Standardization
Cons: Expensive (not covered by insurance)
Cons: Travel to special clinic

32
Q

summary of medical management for OA

A

DMOADs do not exist yet
Corticosteroids have short-term symptomatic benefits and should be adjuncts
Placebo effect from injections (Bannuru 2015, Ayhan 2014)
Viscosupplementation studies that show benefit have high risk of bias
Recommendation: try it if the patient had little to no effect from steroid or can’t have steroid
Surgery:
Joint replacement is highly effective but still considered a salvage procedure
Reduces pain, reduces disability, improves QOL

33
Q

rehab interventions: weight management

A

9-76% reduction in pain following gastric bypass (McGoey 1990)

Pain scores reduced, functional scores improve (Abu-Abeid 2005)

Improved joint space associated with weight loss (Abu-Abeid 2005)

Con: Poor adherence to interventions

Dose response exists (More weight loss more symptomatic improvement) Messier 2018

34
Q

rehab interventions: exercise

A

Maintain and/or improve functional capacity
Supplement diet for weight loss
`No specific recommendations:
Moderate activity (ACSM)
No evidence to support a hierarchy of types of exercise
Whatever the patient likes to do will improve adherence

35
Q

rehab program for exercise OA management

A

Decrease pain, improve function, improve QOL
Quad strength/power = Function
PT had better outcomes through 1 year follow up vs corticosteroid injection

36
Q

bracing for management

A

Unloader braces have some symptomatic benefit

Other braces: Likely placebo/tactile

Braces are generally bulky, uncomfortable, and/or not aesthetically pleasing

37
Q

the debate

A

dont unnecessarily load vs dont change activity pendulum

38
Q

current opinoin

A

Not all OA is the same:
Primary vs secondary with phenotypes of each
It is unlikely there will be one blanket recommendation, each subset will need its own specific recommendations that is also adjusted to the individual patient
The most basic principle of treatment is the risk reward benefit to the patient
Primary OA: Should we promote physical activity (including that with high joint loading) despite the risk of promoting articular cartilage degeneration

Secondary OA: Does the risk reward benefit change given the different pathophysiology?

39
Q

treattment principples summary

A

Promote physical activity for weight management, joint health maintenance, pain/mental health
Weigh the risk reward for whether higher loading activity is appropriate
Use irritability as a guide
Quad strength and power to maintain function
Combination of open and closed chain depending on joint irritability and compensations
Assistive device use for significant gait deviations
Self-management focus
Booster visits currently being explored, watch for evidence

39
Q

the future

A

Harness mechanosensitivity of chondrocytes to promote regeneration
Can we identify specific loading inputs to optimize cartilage health after injury and surgery
Likely in combination with pharm
Use of biologics to regenerate damaged cartilage
Our current post-injury and post-op treatments are focused on short term goals of return to sport and function and have little focus on long-term joint health

40
Q

inflammatory arthritis history

A

UNEXPLAINED joint pain with associated swelling (No MOI but inflammation). Joint(s) can look acutely injured or infected (warm, red, swollen, painful)
Frequently have relapsing remitting presentation
Joints can become damaged over time leading to changes similar to OA (chronic joint degradation)
Make sure you do a high quality systems review as many of these conditions have systemic effects impacting things other than MSK

41
Q

rheumatoid arthritis

A

Fairly common: 0.3 – 1% in US (Alamanos 2006)
Chronic Systemic autoimmune disease that attacks the joints
Hands, wrists, shoulders, elbows, knees, ankles feet
General fatigue
How many joints and any structural deformity
Increased cardiovascular risk
Promote physical activity

42
Q

psoriatic arthritis

A

Autoimmune disease in people with psoriasis that can impact joints
Nail and skin changes
1/3 of people with psoriasis
DIPs, wrists, ankles, knees
Can also impact enthesis (usually heel)

43
Q

lupus

A

Arthritis/arthralgia is present in 95% of patients with SLE
-Mimics RA in 5-15%

44
Q

lymes disease

A

Tends to occur in late stage infection
After systemic symptoms have resolved
Can have intermittent or persistent joint attacks
Lyme bacteria enters joint and can remain
Common in knee
Can have swelling without pain

45
Q

gout

A

Inflamed joints due to urate crystal formation in synovial fluid.
3.9% in US

46
Q

boutonniere

A

PIP flexed and DIP ext

47
Q

swan neck

A

PIP extended, DIP flexed, MCP flexed

48
Q

hitchhikers thumb

A

MCP flexion, IP extension

49
Q

claw toe

A

MTP ext, PIP/DIP flexion

50
Q

IA medical management - disease modifying antirheumatic drugs (DMARDS)

A

Many different DMARD protocols, used in virtually all inflammatory arthritis conditions
Typically have a maintenance dose that is then increased during flares
Trial and error to get maintenance and flare doses right (as little as gets the job done)
Can be combined with corticosteroids to minimize inflammation during flares
Common Pharm
Methotrexate
Leflunomide
Hydroxycholoroquine
Sulfasalazine
Because they inhibit immune response, increased risk of infection

51
Q

IA PT Management

A

Identify when joints are “Hot”: Red, swollen, painful/irritable
During Flare:
Reduce pain and inflammation, promote ROM and maintain strength
Avoid high impact activity
During Remission:
Promote physical activity to limit systemic impacts
Promote moderate intensity exercise and maintenance of strength and ROM to avoid deformity and/or dysfunction

Always use your irritability principles to guide your treatment
Splinting for deformity (covered in Rehab Tech)